BPC-157 + TB-500 Blend Liquid Spray 60mg (30ml) $149.99 1 BOTTLE $149.99/ea 10% OFF 2 BOTTLES $134.99/ea 15% OFF 3 BOTTLES $127.49/ea In stock Description FDA Disclosure & Intended Use Storage Instructions Reviews (0) RUO COA Description Description BPC-157 + TB-500 Spray | Research Peptide Blend Frontier Peptide Labs BPC-157 + TB-500 Liquid Spray is a research-grade peptide blend manufactured exclusively for laboratory research and scientific investigation
Myelin integrity is a central factor

Potential Benefits Enhanced tissue repair Supports recovery of muscles, tendons, and ligaments Anti-inflammatory effects Helps reduce localized inflammation Accelerated healing Promotes cell migration and new blood vessel formation Improved recovery efficiency Beneficial after injury or intense physical activity Synergistic action BPC-157 acts more locally, while TB-500 provides systemic support Dual-Chamber Pen Advantages (15mg + 15mg) Using a Dual-Chamber Pen system: Peptides are stored in separate, sealed compartments (lyophilized + liquid phase) Prevents premature mixing and degradation Allows on-demand reconstitution just before use Ensures higher stability, potency, and consistency Combines the reliability of vials with the convenience and precision of a pen device Dosage & Concentration (Example: Total 30mg / 1ml) Assuming a combined concentration of 30mg / 1ml (BPC-157 15mg + TB-500 15mg): 1 unit = 300 mcg (total peptides) Total content: 100 units (30 mg) Suggested dosing levels: Starting dose : 810 units ( 2.53 mg) Moderate dose : 1520 units ( 4.56 mg) Higher dose : 25 units ( 7.5 mg) (Exact dosing may vary depending on protocol and application.) Usage Guidelines Typically administered 23 times per week Common usage duration: 48 weeks A break between cycles is recommended Note: For research purposes only.

My preferred injection site is tricep
However, some evidence suggests that supplements of 20mcg per day of B12 or more may increase the risk of bone fracturesespecially when combined with excess vitamin B6
Jul 29, 2026, 07:00 ET VANCOUVER, BC and LAS VEGAS, July 29, 2026 /CNW/ -- Hydreight Technologies Inc